| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.IPEJ.2017.10.011 |
| P8608 | Fatcat ID | release_lsflphoaibcujmlud5qn33gqwq |
| P932 | PMC publication ID | 5840852 |
| P698 | PubMed publication ID | 29101013 |
| P50 | author | Isabel Cristina Esposito Sorpreso | Q61146592 |
| Andrés R Pérez-Riera | Q57551205 | ||
| P2093 | author name string | Luiz Carlos de Abreu | |
| Rodrigo Daminello Raimundo | |||
| Raimundo Barbosa-Barros | |||
| Marianne Penachini da Costa de Rezende Barbosa | |||
| P2860 | cites work | Human iPS cell model of type 3 long QT syndrome recapitulates drug-based phenotype correction | Q27322725 |
| Modeling tissue- and mutation- specific electrophysiological effects in the long QT syndrome: role of the Purkinje fiber | Q28539295 | ||
| Asthma and the risk of cardiac events in the Long QT syndrome. Long QT Syndrome Investigative Group | Q33145181 | ||
| Effectiveness and limitations of beta-blocker therapy in congenital long-QT syndrome. | Q33145274 | ||
| Implantable cardioverter defibrillator in high-risk long QT syndrome patients | Q33148945 | ||
| Association of long QT syndrome loci and cardiac events among patients treated with beta-blockers. | Q33151769 | ||
| The Elusive Link Between LQT3 and Brugada Syndrome | Q61850490 | ||
| Evaluation of the spatial aspects of T-wave complexity in the long-QT syndrome | Q73914818 | ||
| Developmental aspects of long QT syndrome type 3 and Brugada syndrome on the basis of a single SCN5A mutation in childhood | Q80383017 | ||
| Pronounced Shortening of QT Interval With Mexiletine Infusion Test in Patients With Type 3 Congenital Long QT Syndrome | Q86848691 | ||
| [High incidence of sudden cardiac death in one family with type-3 long QT syndrome: molecular genetics and electrophysiology mechanism analysis] | Q95553408 | ||
| Long QT syndrome and pregnancy | Q33154884 | ||
| Long-QT syndrome after age 40. | Q33156197 | ||
| Mutation-specific risk in two genetic forms of type 3 long QT syndrome | Q33158299 | ||
| Risk of fatal arrhythmic events in long QT syndrome patients after syncope | Q33158404 | ||
| Subclinical cardiomyopathy and long QT syndrome: an echocardiographic observation | Q33161936 | ||
| Prognostic implications of mutation-specific QTc standard deviation in congenital long QT syndrome | Q33162310 | ||
| Gene-Specific Therapy With Mexiletine Reduces Arrhythmic Events in Patients With Long QT Syndrome Type 3. | Q33166896 | ||
| Clinical Aspects of Type 3 Long-QT Syndrome: An International Multicenter Study | Q33167640 | ||
| Sudden cardiac death and polymorphous ventricular tachycardia in patients with normal QT intervals and normal systolic cardiac function | Q33173911 | ||
| Short-coupled variant of torsade de pointes. A new electrocardiographic entity in the spectrum of idiopathic ventricular tachyarrhythmias | Q33174331 | ||
| The molecular genetics of the long QT syndrome: genes causing fainting and sudden death | Q33175543 | ||
| Influence of the genotype on the clinical course of the long-QT syndrome. International Long-QT Syndrome Registry Research Group. | Q33175786 | ||
| Who are the long-QT syndrome patients who receive an implantable cardioverter-defibrillator and what happens to them?: data from the European Long-QT Syndrome Implantable Cardioverter-Defibrillator (LQTS ICD) Registry | Q33691189 | ||
| High prevalence of genetic variants previously associated with LQT syndrome in new exome data | Q34179377 | ||
| Arrhythmogenic Biophysical Phenotype for SCN5A Mutation S1787N Depends upon Splice Variant Background and Intracellular Acidosis | Q35553358 | ||
| Developmentally regulated SCN5A splice variant potentiates dysfunction of a novel mutation associated with severe fetal arrhythmia | Q35798904 | ||
| Risk for life-threatening cardiac events in patients with genotype-confirmed long-QT syndrome and normal-range corrected QT intervals | Q35904744 | ||
| Purkinje Cells as Sources of Arrhythmias in Long QT Syndrome Type 3. | Q35974167 | ||
| Importance of Knowing the Genotype and the Specific Mutation When Managing Patients with Long QT Syndrome | Q37313296 | ||
| The long QT syndrome: a transatlantic clinical approach to diagnosis and therapy | Q38091053 | ||
| Novel long QT syndrome-associated missense mutation, L762F, in CACNA1C-encoded L-type calcium channel imparts a slower inactivation tau and increased sustained and window current. | Q38890009 | ||
| Trafficking defects and gating abnormalities of a novel SCN5A mutation question gene-specific therapy in long QT syndrome type 3. | Q39722604 | ||
| Molecular determinants of local anesthetic action of beta-blocking drugs: Implications for therapeutic management of long QT syndrome variant 3 | Q39845135 | ||
| QT Dynamics During Exercise in Asymptomatic Children with Long QT Syndrome Type 3. | Q39964440 | ||
| Contribution of sodium channel mutations to bradycardia and sinus node dysfunction in LQT3 families | Q40658302 | ||
| Recognition and significance of pathological T-wave inversions in athletes | Q41590669 | ||
| Y1767C, a novel SCN5A mutation, induces a persistent Na+ current and potentiates ranolazine inhibition of Nav1.5 channels | Q42621770 | ||
| A novel mechanism for LQT3 with 2:1 block: a pore-lining mutation in Nav1.5 significantly affects voltage-dependence of activation | Q42684739 | ||
| Neonatal long QT syndrome type 3 predicted by positive lidocaine challenge | Q43269056 | ||
| Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation | Q43595378 | ||
| Discovery of Dihydrobenzoxazepinone (GS-6615) Late Sodium Current Inhibitor (Late INai), a Phase II Agent with Demonstrated Preclinical Anti-Ischemic and Antiarrhythmic Properties | Q46120532 | ||
| The long QT syndrome: new diagnostic and therapeutic approach in the era of molecular biology. | Q46360306 | ||
| The SCN5A mutation A1180V is associated with electrocardiographic features of LQT3. | Q46367175 | ||
| Return to play? Athletes with congenital long QT syndrome | Q46777813 | ||
| Common Genotypes of Long QT Syndrome in China and the Role of ECG Prediction. | Q50968234 | ||
| Diurnal pattern of QTc interval: how long is prolonged? Possible relation to circadian triggers of cardiovascular events. | Q51049415 | ||
| A Novel SCN5A Mutation Found in a Familial Case of Long QT Syndrome Complicated by Severe Left Ventricular Dysfunction. | Q51239891 | ||
| Vectorcardiography identifies patients with electrocardiographically concealed long QT syndrome. | Q53448030 | ||
| Electrical alternation of the T-wave: Clinical and experimental evidence of its relationship with the sympathetic nervous system and with the long Q-T syndrome | Q58011829 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | long QT syndrome | Q653924 |
| P304 | page(s) | 25-35 | |
| P577 | publication date | 2017-10-31 | |
| P1433 | published in | Indian Pacing and Electrophysiology Journal | Q15734361 |
| P1476 | title | The congenital long QT syndrome Type 3: An update | |
| P478 | volume | 18 |
Search more.